Dataset Information

The relationship between MAFLD and CVD in a health check-up Chinese population: a prospective cohort study.

ABSTRACT:

Background

Cardiovascular disease (CVD) has emerged as the most significant complication and leading cause of death among metabolic-associated fatty liver disease (MAFLD).

Objectives

This study aims to investigate the CVD risk among MAFLD subgroups.

Design

Data of participants from June 2017 to January 2023 in the Physical Examination Center of the Third Hospital of Hebei Medical University were collected. MAFLD were divided into four subgroups: metabolic healthy lean/normal weight MAFLD (MHL), metabolic healthy overweight/obese MAFLD (MHO), metabolic dysfunctional lean/normal weight MAFLD (MDL), and metabolic dysfunctional overweight/obese MAFLD (MDO).